Victor Keen
Director/Board Member at THE CORETEC GROUP INC.
Net worth: 2 M $ as of 2024-08-30
Profile
Victor F.
Keen is the founder of Bantam Pharmaceutical LLC, which was founded in 2015.
He is currently a Director at The Coretec Group, Inc. since 2007, Of-Counsel at Duane Morris LLP, Managing Member at Chelsea, and Managing Member at Ninth Avenue Associates LLC.
Mr. Keen's former positions include Chief Executive Officer & Director at 3DIcon Corp.
from 2013 to 2016, Independent Director at Research Frontiers, Inc. from 1987 to 2013, Associate at Milbank LLP in 1968, Partner at Whitman & Ransom from 1976 to 1983, Principal at The United States Tax Court in 1968, and Partner at Cohen Shapiro Polisher Shiekman & Cohen from 1993 to 1995.
He completed his undergraduate degree at Trinity College (Connecticut) in 1963 and his graduate degree at Harvard Law School in 1966.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CORETEC GROUP INC.
26.70% | 2024-03-20 | 96,048,679 ( 26.70% ) | 2 M $ | 2024-08-30 |
CORETEC GROUP INC.
76.81% | 2024-03-20 | 265,000 ( 76.81% ) | 4 505 $ | 2024-08-30 |
Latest news about Victor Keen
Victor Keen active positions
Companies | Position | Start |
---|---|---|
THE CORETEC GROUP INC. | Director/Board Member | 2024-08-20 |
Ninth Avenue Associates LLC | Corporate Officer/Principal | - |
Chelsea/Village Associates LLC | Corporate Officer/Principal | - |
Duane Morris LLP
Duane Morris LLP Miscellaneous Commercial ServicesCommercial Services Duane Morris LLP provides legal services in the areas of intellectual property, telecommunications, information technologies, energy, water resources, endangered species and international dispute. The firm's clients include the automotive, construction, energy and insurance industries. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Bantam Pharmaceutical LLC
Bantam Pharmaceutical LLC BiotechnologyHealth Technology Bantam Pharmaceutical LLC is a privately funded biopharmaceutical company that specializes in the discovery and development of novel therapeutics for difficult-to-treat hematological and solid tumors. The company is based in New York, NY. The company is currently pursuing an IND application for its lead candidate, BTM-3566, in B-cell malignancies. Bantam's clinical development strategy is focused on areas of unmet clinical need, with initial phase I/II clinical trials planned in relapsed/refractory B-cell hematological malignancies, including diffuse large B-cell lymphoma. The company was founded by Victor F. Keen, and Michael T. Stocum has been the CEO of the company since 2019. | Founder | 2015-07-31 |
Former positions of Victor Keen
Companies | Position | End |
---|---|---|
RESEARCH FRONTIERS INCORPORATED | Director/Board Member | 2013-06-12 |
Cohen Shapiro Polisher Shiekman & Cohen | Corporate Officer/Principal | 1994-12-31 |
Whitman & Ransom
Whitman & Ransom Miscellaneous Commercial ServicesCommercial Services Whitman & Ransom is an American company that provides legal services. | Corporate Officer/Principal | 1982-12-31 |
Milbank LLP
Milbank LLP Miscellaneous Commercial ServicesCommercial Services Milbank LLP provides legal services. It serves corporate, finance, financial restructuring, litigation and arbitration, securities, capital markets, trusts, estates, and exempt organizations, and tax markets. The company was founded in 1866 and is headquartered in New York, NY. | Corporate Officer/Principal | 1975-12-31 |
░░░ ░░░░░░ ░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Victor Keen
Trinity College (Connecticut) | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RESEARCH FRONTIERS INCORPORATED | Consumer Durables |
THE CORETEC GROUP INC. | Technology Services |
Private companies | 9 |
---|---|
3DIcon Corp.
3DIcon Corp. Computer CommunicationsElectronic Technology 3DIcon Corp. develops 3D projection display technologies. Its product, CSpace, provides 360-degree viewable, high-resolution, color images, and is intended for use in government and industrial applications such as air traffic control, medical imaging, automotive and aerospace design, geological visualization, weather visualization, battle space visualization and cargo, baggage. The company sells a software product, Pixel Precision, a simple-to-use image creation, manipulation tool for engineers. 3DIcon was founded by Anthony Martin Keating on August 11, 1995 and is headquartered in Tulsa, OK. | Electronic Technology |
Cohen Shapiro Polisher Shiekman & Cohen | |
Whitman & Ransom
Whitman & Ransom Miscellaneous Commercial ServicesCommercial Services Whitman & Ransom is an American company that provides legal services. | Commercial Services |
Milbank LLP
Milbank LLP Miscellaneous Commercial ServicesCommercial Services Milbank LLP provides legal services. It serves corporate, finance, financial restructuring, litigation and arbitration, securities, capital markets, trusts, estates, and exempt organizations, and tax markets. The company was founded in 1866 and is headquartered in New York, NY. | Commercial Services |
The United States Tax Court | Government |
Ninth Avenue Associates LLC | |
Chelsea/Village Associates LLC | |
Duane Morris LLP
Duane Morris LLP Miscellaneous Commercial ServicesCommercial Services Duane Morris LLP provides legal services in the areas of intellectual property, telecommunications, information technologies, energy, water resources, endangered species and international dispute. The firm's clients include the automotive, construction, energy and insurance industries. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Commercial Services |
Bantam Pharmaceutical LLC
Bantam Pharmaceutical LLC BiotechnologyHealth Technology Bantam Pharmaceutical LLC is a privately funded biopharmaceutical company that specializes in the discovery and development of novel therapeutics for difficult-to-treat hematological and solid tumors. The company is based in New York, NY. The company is currently pursuing an IND application for its lead candidate, BTM-3566, in B-cell malignancies. Bantam's clinical development strategy is focused on areas of unmet clinical need, with initial phase I/II clinical trials planned in relapsed/refractory B-cell hematological malignancies, including diffuse large B-cell lymphoma. The company was founded by Victor F. Keen, and Michael T. Stocum has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Victor Keen